NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation

Benlin Wang, Xianchong Zheng, Qingsheng Hua, Feng Zou, Tao Huang, Jiawei Chen · 2026

Read NAA50-mediated SLU7 stabilization promotes cisplatin resistance in bladder cancer via regulating MAP3K3 mRNA nuclear export and p38 MAPK activation by Benlin Wang, Xianchong Zheng, Qingsheng Hua, Feng Zou, Tao Huang, Jiawei Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13350617.txt.

Description

Benlin Wang and co-authors trace a drug resistance circuit in bladder cancer in a 2026 study. Cisplatin is the front line drug for invasive bladder tumors, but resistance blunts it. A splicing factor stood out: resistant cells carried far more of it, and patients with high levels fared worse.

Silencing the factor restored drug sensitivity and shut down a growth signal path. The mechanism surprised the team: the factor ferries a key messenger RNA out of the nucleus, a side job apart from splicing. A second protein shields the factor from destruction by tagging its head. Blocking that shield collapsed the whole circuit and re-sensitized tumors in mice, pointing to a fresh drug target.

Catalog record

CREATORBenlin Wang, Xianchong Zheng, Qingsheng Hua, Feng Zou, Tao Huang, Jiawei Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13350617

Browse the full library · About the Tower of Babel